These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 16603611)

  • 1. Laboratory diagnostic systems for Ebola and Marburg hemorrhagic fevers developed with recombinant proteins.
    Saijo M; Niikura M; Ikegami T; Kurane I; Kurata T; Morikawa S
    Clin Vaccine Immunol; 2006 Apr; 13(4):444-51. PubMed ID: 16603611
    [No Abstract]   [Full Text] [Related]  

  • 2. Marburg and Ebola viruses.
    Feldmann H; Klenk HD
    Adv Virus Res; 1996; 47():1-52. PubMed ID: 8895830
    [No Abstract]   [Full Text] [Related]  

  • 3. Tissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg viruses.
    Martines RB; Ng DL; Greer PW; Rollin PE; Zaki SR
    J Pathol; 2015 Jan; 235(2):153-74. PubMed ID: 25297522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral haemorrhagic fevers caused by Lassa, Ebola and Marburg viruses.
    Curtis N
    Adv Exp Med Biol; 2006; 582():35-44. PubMed ID: 16802617
    [No Abstract]   [Full Text] [Related]  

  • 5. [Ebola virus and Marburg virus].
    Morikawa S
    Nihon Rinsho; 2003 Mar; 61 Suppl 3():544-9. PubMed ID: 12718026
    [No Abstract]   [Full Text] [Related]  

  • 6. [Stabilization of peroxidase conjugates used in enzyme immunoassay systems to detect Ebola and Marburg virus antigens].
    Pirozhkov AP; Borisevich IV; Snetkova OIu; Androshchuk IA; Syromiatnikova SI; Khmelev AL; Shatokhina IV; Kudrin VIu; Timofeev MA; Pantiukhov VB; Borisevich SV; Markov VI; Bondarev VP
    Vopr Virusol; 2010; 55(1):45-8. PubMed ID: 20364672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Survivors of Disease Outbreaks Caused by Ebola or Marburg Virus Exhibit Cross-Reactive and Long-Lived Antibody Responses.
    Natesan M; Jensen SM; Keasey SL; Kamata T; Kuehne AI; Stonier SW; Lutwama JJ; Lobel L; Dye JM; Ulrich RG
    Clin Vaccine Immunol; 2016 Aug; 23(8):717-24. PubMed ID: 27335383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzyme-linked immunosorbent assays for detection of antibodies to Ebola and Marburg viruses using recombinant nucleoproteins.
    Saijo M; Niikura M; Morikawa S; Ksiazek TG; Meyer RF; Peters CJ; Kurane I
    J Clin Microbiol; 2001 Jan; 39(1):1-7. PubMed ID: 11136739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging diseases. On the trail of Ebola and Marburg viruses.
    Balter M
    Science; 2000 Nov; 290(5493):923-5. PubMed ID: 11184732
    [No Abstract]   [Full Text] [Related]  

  • 10. Laboratory diagnosis of Ebola and Marburg hemorrhagic fever.
    Grolla A; Lucht A; Dick D; Strong JE; Feldmann H
    Bull Soc Pathol Exot; 2005 Sep; 98(3):205-9. PubMed ID: 16267962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lessons learned during active epidemiological surveillance of Ebola and Marburg viral hemorrhagic fever epidemics in Africa.
    Allaranga Y; Kone ML; Formenty P; Libama F; Boumandouki P; Woodfill CJ; Sow I; Duale S; Alemu W; Yada A
    East Afr J Public Health; 2010 Mar; 7(1):30-6. PubMed ID: 21413569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis of filoviral haemorrhagic fevers.
    Mahanty S; Bray M
    Lancet Infect Dis; 2004 Aug; 4(8):487-98. PubMed ID: 15288821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ebola and Marburg hemorrhagic fever viruses: update on filoviruses].
    Leroy E; Baize S; Gonzalez JP
    Med Trop (Mars); 2011 Apr; 71(2):111-21. PubMed ID: 21695865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A retrospective cohort investigation of seroprevalence of Marburg virus and ebolaviruses in two different ecological zones in Uganda.
    Nyakarahuka L; Schafer IJ; Balinandi S; Mulei S; Tumusiime A; Kyondo J; Knust B; Lutwama J; Rollin P; Nichol S; Shoemaker T
    BMC Infect Dis; 2020 Jul; 20(1):461. PubMed ID: 32611400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Considerations in the Use of Nonhuman Primate Models of Ebola Virus and Marburg Virus Infection.
    Geisbert TW; Strong JE; Feldmann H
    J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S91-7. PubMed ID: 26063223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single shot against Ebola and Marburg virus.
    Baize S
    Nat Med; 2005 Jul; 11(7):720-1. PubMed ID: 16015361
    [No Abstract]   [Full Text] [Related]  

  • 17. Characteristics of Filoviridae: Marburg and Ebola viruses.
    Beer B; Kurth R; Bukreyev A
    Naturwissenschaften; 1999 Jan; 86(1):8-17. PubMed ID: 10024977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identity and validity of conserved B cell epitopes of filovirus glycoprotein: towards rapid diagnostic testing for Ebola and possibly Marburg virus disease.
    Babirye P; Musubika C; Kirimunda S; Downing R; Lutwama JJ; Mbidde EK; Weyer J; Paweska JT; Joloba ML; Wayengera M
    BMC Infect Dis; 2018 Oct; 18(1):498. PubMed ID: 30285648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ebola and Marburg virus vaccines.
    Reynolds P; Marzi A
    Virus Genes; 2017 Aug; 53(4):501-515. PubMed ID: 28447193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biophysical characterization and conformational stability of Ebola and Marburg virus-like particles.
    Hu L; Trefethen JM; Zeng Y; Yee L; Ohtake S; Lechuga-Ballesteros D; Warfield KL; Aman MJ; Shulenin S; Unfer R; Enterlein SG; Truong-Le V; Volkin DB; Joshi SB; Middaugh CR
    J Pharm Sci; 2011 Dec; 100(12):5156-73. PubMed ID: 21858822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.